FDA approves Zepbound for obesity management alongside diet and exercise. A promising new option for weight control, it's the second once-weekly injectable after Wegovy...

Explore the VITAL-CGM trial, which investigates if using a combination of CGM and WeightWatchers can lower A1C in people with type 2 diabetes.

Explore the link between obesity, diabetes, and breast cancer risk. Learn how treatments like bariatric surgery and medications can reduce this risk and aid in diabetes...

In case you missed them, here are our top stories from October 2023 that cover upcoming therapies, groundbreaking research, and more.

Lilly’s SURMOUNT-4 trial shows that Mounjaro (tirzepatide) offers remarkable weight loss in patients with a BMI of over 30. Full SURMOUNT-3 trial results highlighted the...

Data presented at EASD 2023 reveals orforglipron's potential in type 2 diabetes management. The new oral GLP-1 medication demonstrated significant reductions for A1C and...

Survodutide, a GLP-1/glucagon dual receptor agonist, shows promising weight loss results in a clinical trial. The injectable medication, developed by Zealand and...

At the 59th European Association for the Study of Diabetes in Germany, an expert panel discussed the tremendous cardiovascular health benefits of limiting body weight...

Early research finds that people with type 1 diabetes who started taking Ozempic (semaglutide) were able to reduce their insulin dose. This research suggests potential...

Novo Nordisk's REDEFINE trials test CagriSema for weight and heart health in adults with type 2 diabetes and/or obesity. Participate and shape diabetes care.

Uncover the complex link between obesity, asthma, and diabetes, plus effective management strategies to deal with allergens during peak allergy season.

Learn about the importance of Ozempic – the new “miracle” diet drug that celebrities are using for weight loss – in diabetes care and weight loss while challenging...

The debate over how many carbohydrates people should consume has raged for decades. Experts share their perspectives on low, very low, and moderate carb diets for ideal...

Obesity management options include lifestyle changes, medication, and surgery. Here's what you need to know to make informed decisions about what treatments are optimal...

Looking for natural ways to help lower your blood sugar? Try exercise, fiber supplements, apple cider vinegar, fenugreek, zinc, and probiotic foods. Always consult with...

Uncover phase 2 clinical trial results of CagriSema, a promising diabetes treatment showing improvements in A1C, weight loss, and time in range.

Pfizer propels clinical trials for danuglipron, a novel oral GLP-1 medication for obesity and type 2 diabetes, with promising preliminary results for A1C and weight loss.

At the 17th annual Diabetes Forum at ADA 2023, the diaTribe Foundation and TCOYD moderated an expert panel that discussed access and equity issues, breakthrough...

Clinical trial participants taking retatrutide for obesity experienced an average of 24% in body weight reduction over 48 weeks. Lead scientists shared their findings at...

Results from a recent clinical trial showed the new medication survodutide may be a useful treatment tool for weight loss. People with overweight or obesity on the...